Heparin cofactor II is more sensitive than antithrombin to secretory impairment arising from mutations introduced into its carboxy-terminal region
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 113 (2) , 163-173
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Serpin Structure, Mechanism, and FunctionChemical Reviews, 2002
- Interactions Causing the Kinetic Trap in Serpin Protein FoldingJournal of Biological Chemistry, 2002
- Heparin cofactor II inhibits arterial thrombosis after endothelial injuryJournal of Clinical Investigation, 2002
- Genetic risk factors of venous thrombosisHuman Genetics, 2001
- The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse ProteinsJournal of Biological Chemistry, 2001
- Structure of a serpin–protease complex shows inhibition by deformationNature, 2000
- Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 Å and full insertion of the reactive center loop into β-sheet AProceedings of the National Academy of Sciences, 1999
- What do dysfunctional serpins tell us about molecular mobility and disease?Nature Structural & Molecular Biology, 1995
- General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitorBlood Coagulation & Fibrinolysis, 1993
- Implications of the three-dimensional structure of .alpha.1-antitrypsin for structure and function of serpinsBiochemistry, 1989